|
Journal of Lipid Research, Vol 28, 455-463, Copyright © 1987 by Lipid Research, Inc.
A rapid micromethod for apolipoprotein E phenotyping directly in serum
LM Havekes, P de Knijff, U Beisiegel, J Havinga, M Smit and E Klasen
A new method for the apolipoprotein E phenotyping has been developed. The
method is based on isoelectric focusing of either delipidated or
guanidine-HC1-treated serum or plasma in a horizontal slab gel system
followed by immunoblotting using either polyclonal or monoclonal anti-
apolipoprotein E antibodies as first antibody. Apolipoprotein E phenotyping
with this method in 200 serum samples that had been stored at -20 degrees C
for more than one year gave exactly the same results as obtained with the
conventional method based on isoelectric focusing of delipidated very low
density lipoproteins isolated from fresh serum followed by protein
staining. Compared with the conventional method, the present method is less
laborious because ultracentrifugation to isolate VLDL is not needed; it is
suitable for large scale screening purposes; it needs only a few
microliters of serum or plasma, and can easily be performed with samples
with low concentrations of apolipoprotein E.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Millar, C. Maugeais, K. Ikewaki, D. M. Kolansky, P.H. R. Barrett, E. C. Budreck, R. C. Boston, N. Tada, S. Mochizuki, J. C. Defesche, et al.
Complete Deficiency of the Low-Density Lipoprotein Receptor Is Associated With Increased Apolipoprotein B-100 Production
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2005;
25(3):
560 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Stephens, M. M. Sozen, R. A. Whittall, M. J. Caslake, D. Bedford, J. Acharya, S. J. Hurel, and S. E. Humphries
Three Novel Mutations in the Apolipoprotein E Gene in a Sample of Individuals with Type 2 Diabetes Mellitus
Clin. Chem.,
January 1, 2005;
51(1):
119 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Simonen, H. K. Gylling, and T. A. Miettinen
Diabetes Contributes to Cholesterol Metabolism Regardless of Obesity
Diabetes Care,
September 1, 2002;
25(9):
1511 - 1515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M van Dam, M Zwart, F de Beer, A H M Smelt, M H Prins, M D Trip, L M Havekes, P J Lansberg, and J J P Kastelein
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia
Heart,
September 1, 2002;
88(3):
234 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Dik, C. Jonker, H. C. Comijs, L. M. Bouter, J. W.R. Twisk, G. J. van Kamp, and D. J.H. Deeg
Memory complaints and APOE-{epsilon}4 accelerate cognitive decline in cognitively normal elderly
Neurology,
December 26, 2001;
57(12):
2217 - 2222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Rajaratnam, H. Gylling, and T. A. Miettinen
Cholesterol Absorption, Synthesis, and Fecal Output in Postmenopausal Women With and Without Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2001;
21(10):
1650 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shahmanesh, H. Jaleel, Y. DeSilva, J. D C Ross, M. Caslake, and R. Cramb
Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype
Sex Transm Inf,
August 1, 2001;
77(4):
283 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koch, N. Donarski, K. Goetze, M. Kreckel, H.-J. Stuerenburg, C. Buhmann, and U. Beisiegel
Characterization of four lipoprotein classes in human cerebrospinal fluid
J. Lipid Res.,
July 1, 2001;
42(7):
1143 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Relas, H. Gylling, and T. A. Miettinen
Fate of intravenously administered squalene and plant sterols in human subjects
J. Lipid Res.,
June 1, 2001;
42(6):
988 - 994.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Relas, H. Gylling, R. A. Rajaratnam, and T. A. Miettinen
Postprandial Retinyl Palmitate and Squalene Metabolism Is Age Dependent
J. Gerontol. A Biol. Sci. Med. Sci.,
November 1, 2000;
55(11):
515B - 521.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. G. Dik, D. J. H. Deeg, L. M. Bouter, E. H. Corder, A. Kok, and C. Jonker
Stroke and Apolipoprotein E {epsilon}4 Are Independent Risk Factors for Cognitive Decline : A Population-Based Study
Stroke,
October 1, 2000;
31(10):
2431 - 2436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Dik, C. Jonker, L. M. Bouter, M. I. Geerlings, G. J. van Kamp, and D. J. H. Deeg
APOE-{epsilon}4 is associated with memory decline in cognitively impaired elderly
Neurology,
April 11, 2000;
54(7):
1492 - 1497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Packard, T. Demant, J. P. Stewart, D. Bedford, M. J. Caslake, G. Schwertfeger, A. Bedynek, J. Shepherd, and D. Seidel
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions
J. Lipid Res.,
February 1, 2000;
41(2):
305 - 318.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. F. Vuorio, H. Gylling, H. Turtola, K. Kontula, P. Ketonen, and T. A. Miettinen
Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH-North Karelia Mutation
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2000;
20(2):
500 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. G. Sijbrands, M. J. V. Hoffer, A. E. Meinders, L. M. Havekes, R. R. Frants, A. H. M. Smelt, and P. De Knijff
Severe Hyperlipidemia in Apolipoprotein E2 Homozygotes Due to a Combined Effect of Hyperinsulinemia and an SstI Polymorphism
Arterioscler. Thromb. Vasc. Biol.,
November 1, 1999;
19(11):
2722 - 2729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wang, K. Nakajima, E. T. Leary, G. R. Warnick, J. S. Cohn, P. N. Hopkins, L. L. Wu, D. D. Cilla, J. Zhong, and R. J. Havel
Ratio of Remnant-like Particle-Cholesterol to Serum Total Triglycerides Is an Effective Alternative to Ultracentrifugal and Electrophoretic Methods in the Diagnosis of Familial Type III Hyperlipoproteinemia
Clin. Chem.,
November 1, 1999;
45(11):
1981 - 1987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mero, L. Suurinkeroinen, M. Syvänne, P. Knudsen, H. Yki-Järvinen, and M.-R. Taskinen
Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant
J. Lipid Res.,
September 1, 1999;
40(9):
1663 - 1670.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Jonker, B. Schmand, J. Lindeboom, L. M. Havekes, and L. J. Launer
Association Between Apolipoprotein E{epsilon}4 and the Rate of Cognitive Decline in Community-Dwelling Elderly Individuals With and Without Dementia
Arch Neurol,
August 1, 1998;
55(8):
1065 - 1069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mero, A. Van Tol, L. M. Scheek, T. Van Gent, C. Labeur, M. Rosseneu, and M-R. Taskinen
Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities
J. Lipid Res.,
July 1, 1998;
39(7):
1493 - 1502.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Mero, M. Syvanne, B. Eliasson, U. Smith, and M.-R. Taskinen
Postprandial Elevation of ApoB-48-Containing Triglyceride-Rich Particles and Retinyl Esters in Normolipemic Males Who Smoke
Arterioscler. Thromb. Vasc. Biol.,
October 1, 1997;
17(10):
2096 - 2102.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. A. Boer, C. Ehnholm, H.-J. Menzel, L. M. Havekes, M. Rosseneu, D. S. J. O'Reilly, L. Tiret, and f. t. E. Group
Interactions Between Lifestyle-Related Factors and the ApoE Polymorphism on Plasma Lipids and Apolipoproteins : The EARS Study
Arterioscler. Thromb. Vasc. Biol.,
September 1, 1997;
17(9):
1675 - 1681.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Malmstrom, C. J. Packard, T. D. G. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M.-R. Taskinen
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men
Arterioscler. Thromb. Vasc. Biol.,
July 1, 1997;
17(7):
1454 - 1464.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M.-F. Hau, A. H.M. Smelt, A. J.G.H. Bindels, E. J.G. Sijbrands, A. Van der Laarse, W. Onkenhout, W. van Duyvenvoorde, and H. M.G. Princen
Effects of Fish Oil on Oxidation Resistance of VLDL in Hypertriglyceridemic Patients
Arterioscler. Thromb. Vasc. Biol.,
September 1, 1996;
16(9):
1197 - 1202.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Gaw, C. J. Packard, G. M. Lindsay, E. F. Murray, B. A. Griffin, M. J. Caslake, I. Colquhoun, D. J. Wheatley, A. R. Lorimer, and J. Shepherd
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
Arterioscler. Thromb. Vasc. Biol.,
February 1, 1996;
16(2):
236 - 249.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Syvanne, J. Kahri, K. S. Virtanen, and M.-R. Taskinen
HDLs Containing Apolipoproteins A-I and A-II (LpA-I:A-II) as Markers of Coronary Artery Disease in Men With Non–Insulin- Dependent Diabetes Mellitus
Circulation,
August 1, 1995;
92(3):
364 - 370.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Gylling, K. Kontula, and T. A. Miettinen
Cholesterol Absorption and Metabolism and LDL Kinetics in Healthy Men With Different Apoprotein E Phenotypes and Apoprotein B Xba I and LDL Receptor Pvu II Genotypes
Arterioscler. Thromb. Vasc. Biol.,
February 1, 1995;
15(2):
208 - 213.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. H. Stengard, K. E. Zerba, J. Pekkanen, C. Ehnholm, A. Nissinen, and C. F. Sing
Apolipoprotein E Polymorphism Predicts Death From Coronary Heart Disease in a Longitudinal Study of Elderly Finnish Men
Circulation,
January 15, 1995;
91(2):
265 - 269.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1987 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|